Enterococcus faecium Clade Competition in the Presence of β-Lactam Antibiotics in a Mouse GI Tract Colonization Model

Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0090322. doi: 10.1128/aac.00903-22. Epub 2022 Oct 18.

Abstract

Previously, we showed that Enterococcus faecium clade B strains outcompeted health care-associated clade A1 strains in murine gastrointestinal colonization. Here, parenterally administered piperacillin-tazobactam and ceftriaxone significantly promoted colonization by clade A1 over clade B strains except that ceftriaxone, at the dose used, did not favor the least β-lactam-resistant A1 strain. The advantage that β-lactam administration gives to more highly ampicillin-resistant E. faecium over ampicillin-susceptible strains mirrors what occurs in hospitalized patients administered these antibiotics.

Keywords: E. faecium; ampicillin resistant; ceftriaxone; mouse GI colonization; piperacillin-tazobactam.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Ampicillin / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / pharmacology
  • Enterococcus faecium*
  • Gastrointestinal Tract
  • Mice
  • Monobactams
  • beta-Lactams / pharmacology

Substances

  • Ceftriaxone
  • Anti-Bacterial Agents
  • Monobactams
  • beta-Lactams
  • Ampicillin